Health Economics for Medical Devices: Addressing Payer Concerns with a Successful Value Proposition
|発行||Cutting Edge Information||商品コード||311714|
|出版日||ページ情報||英文 63 Pages
|医療機器のヘルスエコノミクス：成功する価値命題を用いて医療費支払い者の懸念に対処する Health Economics for Medical Devices: Addressing Payer Concerns with a Successful Value Proposition|
|出版日: 2014年04月30日||ページ情報: 英文 63 Pages||
当レポートでは、医療機器のヘルスエコノミクス(医療経済)について調査し、HEOR(Health Economics and Outcomes Research)グループの構造を示す実例・ケーススタディ、HEORグループの人材配置およびアウトソーシング活動のベンチマークとベストプラクティス、各エクスペリエンスレベルにおけるHEORポジションの補償データ、クラスII・クラスIII医療機器の年間HEOR支出データ、主なHEOR研究に関する戦略的提言と分析、およびグループタイプ・地域別のデータなどを提供しています。
Due to their high costs, medical devices are early and easy targets for cost-cutting measures. To succeed against these increasing pressures, device companies arm themselves with health economics data to satisfy payer requirements and maintain optimal price levels. The benchmarks and best practices in this report guide medical device firms to take several steps toward meeting payer needs throughout the product lifecycle:
The increasing levels of resources dedicated to health economics and outcomes research highlight the growing importance of these functions. This chapter explores device organizations' HEOR structures and staffing resources. Research in this chapter shows prevalent HEOR team structures at the global and country levels. Data also show how teams leverage staff to complete various cross-functional activities throughout a product's lifecycle. Finally, the chapter examines key trends impacting health economics teams' operations.
17 charts detailing structure, outsourcing and functions associated with HEOR groups at medical device companies. Where relevant, data are broken down by geography (global/country-level groups).
This chapter discusses the major activities and cost drivers for HEOR groups at medical device companies. It covers the differences in HEOR spending between Class II and Class III medical devices, as well as how companies should look at the marketplace to understand the role that HEOR groups can play. Companies should make sure that compensation rates for HEOR employees remain competitive. The chapter also examines outsourcing practices and how companies balance in-house activities and third-party vendors.
7 charts detailing spending and compensation benchmarks for HEOR companies. Where relevant, data are split by category (overhead, salaries, HEOR studies), by activity (managing vendors, government/private payer information, valuating products, organizing data, clinical trial design) and by level (HEOR department head, management, HOL).
This chapter shows the costs and durations of different types of HEOR studies medical device companies conduct to best achieve reimbursement. It also covers the number of each type of study that surveyed companies conduct each year, from 2012 through 2014. This data analysis examines the many different reasons - ranging from cost to marketplace to payers - a company chooses one HEOR study over another.
13 charts detailing duration, cost and number of studies conducted by HEOR groups. Where relevant, data are split by study type and by geography (global/country).
Number of studies conducted by global HEOR teams, by company:
Cost of studies conducted by device HEOR teams, by company: